Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.
Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, Dos Santos AÁ, Dias GBM, Vargas JE, Puga R, Mayer FQ, Maito F, Zárate-Bladés CR, Ajami NJ, Sant'Ana MR, Candreva T, Rodrigues HG, Schmiele M, Silva Clerici MTP, Proença-Modena JL, Vieira AT, Mackay CR, Mansur D, Caballero MT, Marzec J, Li J, Wang X, Bell D, Polack FP, Kleeberger SR, Stein RT, Vinolo MAR, de Souza APD.
Antunes KH, et al. Among authors: schmiele m.
Nat Commun. 2019 Jul 22;10(1):3273. doi: 10.1038/s41467-019-11152-6.
Nat Commun. 2019.
PMID: 31332169
Free PMC article.